Literature DB >> 10527350

Donor site morbidity in the iliac crest bone graft.

N M Hill1, J G Horne, P A Devane.   

Abstract

BACKGROUND: Open iliac crest bone grafting is a common surgical procedure with recognized short-term complications. The present paper documents the medium- to long-term complications and level of patient satisfaction following the procedure.
METHODS: Seventy-three patients undergoing an open iliac crest bone graft over the past 6 years at Wellington Hospital were retrospectively reviewed. All patients completed a postal questionnaire which assessed their current pain, sensory changes in and below the scar, scar appearance and overall appearance with the bone graft donor site.
RESULTS: Sixteen patients (21.9%) reported pain, 11 patients (15%) stated that their scar was sensitive to touch and 19 patients (22%) reported a degree of sensory change below the scar. Six patients (8.2%) felt that the scar appearance was totally unacceptable. Overall satisfaction, however, was high with 70 patients (95.8%) 'fairly satisfied' or 'totally satisfied' with their iliac crest donor site.
CONCLUSIONS: Bone grafting from the iliac crest is a relatively benign procedure in terms of patient satisfaction, and the most significant morbidity is pain.

Entities:  

Mesh:

Year:  1999        PMID: 10527350     DOI: 10.1046/j.1440-1622.1999.01674.x

Source DB:  PubMed          Journal:  Aust N Z J Surg        ISSN: 0004-8682


  12 in total

1.  Bioreactor-based bone tissue engineering: the influence of dynamic flow on osteoblast phenotypic expression and matrix mineralization.

Authors:  Xiaojun Yu; Edward A Botchwey; Elliot M Levine; Solomon R Pollack; Cato T Laurencin
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-26       Impact factor: 11.205

Review 2.  Cartilage and bone tissue engineering for reconstructive head and neck surgery.

Authors:  Nicole Rotter; Andreas Haisch; Markus Bücheler
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-12-10       Impact factor: 2.503

3.  Pain from donor site after anterior cervical fusion with bone graft: a prospective randomized study with 12 months of follow-up.

Authors:  M Skeppholm; C Olerud
Journal:  Eur Spine J       Date:  2012-08-14       Impact factor: 3.134

4.  Calcium sulfate as bone graft substitute in the treatment of osseous bone defects, a prospective study.

Authors:  Yashavantha Kumar C; Nalini K B; Jagdish Menon; Dilip Kumar Patro; Banerji B H
Journal:  J Clin Diagn Res       Date:  2013-12-15

5.  Donor site morbidity following iliac crest bone harvesting for cervical fusion: a comparison between minimally invasive and open techniques.

Authors:  Raymond Pollock; Ilhan Alcelik; Chandra Bhatia; Graham Chuter; Kiran Lingutla; Chakravarty Budithi; Manoj Krishna
Journal:  Eur Spine J       Date:  2008-04-04       Impact factor: 3.134

6.  The effect of risedronate on posterior lateral spinal fusion in a rat model.

Authors:  Ali Riza Gezici; Rüçhan Ergün; Kamil Gürel; Fahri Yilmaz; Onder Okay; Omer Bozdoğan
Journal:  J Korean Neurosurg Soc       Date:  2009-07-31

Review 7.  Efficacy of minimally invasive techniques for enhancement of fracture healing: evidence today.

Authors:  Ippokratis Pountos; Theodora Georgouli; George Kontakis; Peter V Giannoudis
Journal:  Int Orthop       Date:  2010-02       Impact factor: 3.075

8.  Comparing Morbidities of Bone Graft Harvesting from the Olecranon Process and the Distal Radius.

Authors:  Alan J Micev; David M Kalainov; William Slikker; Madeleine Ma; Ross J Richer; Mark S Cohen
Journal:  Plast Reconstr Surg Glob Open       Date:  2016-02-19

Review 9.  The role of perfusion bioreactors in bone tissue engineering.

Authors:  Diana Alves Gaspar; Viviane Gomide; Fernando Jorge Monteiro
Journal:  Biomatter       Date:  2012 Oct-Dec

10.  EVALUATION OF SURGICAL TREATMENT OF FRACTURES OF THORACOLUMBAR SPINE WITH THIRD-GENERATION MATERIAL FOR INTERNAL FIXATION.

Authors:  Adalberto Bortoletto; Luiz Cláudio Lacerda Rodrigues; Marcelo Hide Matsumoto
Journal:  Rev Bras Ortop       Date:  2015-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.